Intended for US audience only.
Hemophilia Therapies
Providing innovative recombinant and plasma-derived factor and inhibitor management therapies highlights our commitment to choice and illuminates our investment in research and development.
Looking to the future, Baxter is dedicated to improving current therapies. We will continue to invest in research to offer new and better ways to manage hemophilia A—innovations inspired by listening to you.
ADVATE
[Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method]
The recombinant factor VIII therapy chosen more than any other.1*
Please see Prescribing Information and Important Safety Information:
View ADVATE Full Prescribing Information (PDF).
* Based on number of units distributed in the US, beginning May 2007.
RECOMBINATE
[Antihemophilic Factor (Recombinant)]
The first genetically engineered, non-plasma-derived factor VIII.3
Please see Prescribing Information and Important Safety Information:
View Full Prescribing Information RECOMBINATE supplied with BAXJECTII (PDF) View Full Prescribing Information RECOMBINATE supplied with Double Ended Needles (PDF)
HEMOFIL M
[Antihemophilic Factor (Human), Method M, Monoclonal Purified]
The first monoclonal antibody purified, solvent detergent–treated factor VIII.3
Please see Prescribing Information and Important Safety Information.
MONARC-M
[Antihemophilic Factor (Human), Method M, Monoclonal Purified]
A monoclonal antibody purified, solvent detergent–treated factor VIII.
Please see Prescribing Information and Important Safety Information.
FEIBA VH
[Anti-inhibitor Coagulant Complex]
An activated prothrombin complex concentrate with 30 years of experience in the management of hemophilia patients with inhibitors.
Please see Prescribing Information and Important Safety Information.
BEBULIN VH
[Factor IX Complex] Vapor Heated
Bebulin VH is used primarily to treat bleeds in patients with hemophilia B (Christmas disease).
Please see Prescribing Information and Important Safety Information.
BAXJECT II
A needle-less transfer device that’s as easy as 1-2-3
About Hemophilia
Find out where hemophilia comes from, how treatment works, and how to help your child live well with it. Go to About Hemophilia.
Patient Resources
Learn more about hemophilia and how to better manage it with a variety of online and offline tools. Find them in Patient Resources.
Community Programs
Help your child or loved one gain the life skills and education to live independently as he plans for school and career. Learn more in Community Programs.
Insurance and Advocacy
Having the right insurance coverage will always be essential for your continued access to the therapy your family uses. Get started in Insurance and Advocacy.
Clinical Initiatives
See how your doctor and the medical community receive training, education and support in managing hemophilia. Visit Clinical Initiatives.
- Industry, financial, and research reports on file. Westlake Village, CA: Baxter Healthcare Corporation.
- U.S. Food and Drug Administration. www.fda.gov/bbs/topics/NEWS/NEW00312.html. Accessed March 2008.
- Kingdon HS, Lundblad RL. An adventure in biotechnology: the development of haemophilia A therapeutics — from whole-blood transfusion to recombinant DNA to gene therapy. Biotechnol. Appl. Biochem. 2002; 35:141-148.
